Related Experiment Videos
Growth retardation during early organogenesis in embryos of experimentally diabetic rats
Insights
Maternal diabetes in rats significantly hinders early embryo growth and development, evidenced by reduced size and somite number. These findings highlight diabetes
Area of Science:
- Developmental Biology
- Reproductive Medicine
- Endocrinology
Background:
- Poorly regulated maternal diabetes is a known risk factor for adverse pregnancy outcomes.
- Early embryonic development is a critical period sensitive to metabolic disturbances.
Purpose of the Study:
- To investigate the impact of maternal diabetes on early rat embryogenesis.
- To determine if maternal diabetes causes growth retardation and developmental abnormalities in early embryos.
Main Methods:
- Embryos from streptozotocin-induced diabetic rats were examined at 11.5 days of gestation.
- Measurements included crown-rump length, somite number, total protein, and DNA content.
Main Results:
- Embryos from diabetic rats showed significant reductions in crown-rump length and somite number.
- Protein and DNA content were reduced, leading to increased protein/DNA ratios.
- No gross neural dysmorphogenic lesions were observed disproportionate to overall growth retardation.
Conclusions:
- Maternal diabetes compromises early intra-uterine growth and development, affecting the period of placental circulation establishment.
- Further research is needed to elucidate multifactorial determinants and the link to later-stage dysmorphogenesis.
Abstract:
Embryos from rats rendered diabetic with streptozotocin for 1 wk or more before conception were examined on day 11.5 of gestation (i.e., at the 26-29-somite stage of normal rat embryonic development). The studies were designed to assess whether poorly regulated maternal diabetes is associated with demonstrable abnormalities even during this early phase of embryogenesis. We found that manifest retardations in growth and development were invariably present as judged by significant reductions in crown-rump length and somite number, respectively. Total protein and DNA content of the embryos were also reduced, although not symmetrically, so that protein/DNA ratios were increased. Gross dysmorphogenic lesions in neural tissue disproportional to the overall growth retardation at 11.5 days could not be demonstrated. The findings suggest that maternal diabetes can compromise intra-uterine growth and development during the period preceding and coinciding with the establishment of circulation in the allantoic placenta. The possible multifactorial determinants remain to be elucidated. It also remains to be established whether the early embryotoxicity provides a setting conducive to the increased dysmorphogenesis that is traditionally recognized during the later stages of pregnancy complicated by diabetes.